Lv2
158 积分 2026-04-20 加入
Artificial Intelligence-Based Assessment of Pathologic Response to Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer: An International Multicenter Cohort Study
21天前
已完结
Artificial Intelligence–Based Assessment of Pathologic Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer: An International Multicenter Cohort Study
21天前
已关闭
Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non-Small Cell Lung Cancer: A Single-Arm Phase II Trial
21天前
已完结
Divergent Tumor Immune Microenvironment and Response to Neoadjuvant Chemoimmunotherapy in Resectable Non–Small Cell Lung Cancer: A Single-Arm Phase II Trial
21天前
已关闭
Baseline Tumor Proliferation and Ki-67 Are Associated With Pathological Response to Neoadjuvant Chemoimmunotherapy in Non-Small Cell Lung Cancer
1个月前
已完结
Baseline Tumor Proliferation and Ki-67 Are Associated With Pathological Response to Neoadjuvant Chemoimmunotherapy in Non–Small Cell Lung Cancer
1个月前
已关闭
Delta-radiomics features for predicting the major pathological response to neoadjuvant chemoimmunotherapy in non-small cell lung cancer
1个月前
已完结
Cross-attention multimodal fusion for EGFR mutation prediction: A predictive model using CT and whole-slide images
1个月前
已完结
Pretreatment radiomic biomarker for immunotherapy responder prediction in stage IB–IV NSCLC (LCDigital-IO Study): a multicenter retrospective study
1个月前
已完结
The additive effect of high-risk tumor features on long-term survival and recurrence in pathologic stage I non–small cell lung cancer
1个月前
已完结
皖公网安备34019202002308
